alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
ex10-1.htm


	
 
	
PHILOU VENTURES, LLC
	
Exhibit 10.1



 

 

 

Date: September 20, 2016     

 

 

 

 

Digital Power Corporation

48430 Lakeview Blvd.

Fremont, CA 94538-3158

 

Telkoor Telecom Ltd.

5 Giborei Israel

Netanya 42293 Israel

 

Re:     Waiver

 

Dear Sirs:

 

Reference is hereby made to that certain Securities Purchase Agreement, dated as September 4, 2016 (the “Agreement”) by and among Digital Power Corporation, a California corporation (the “Company”), Philou Ventures, LLC, a Wyoming limited liability company (the “Purchaser”), and Telkoor Telecom Ltd., an Israeli corporation. All capitalized terms used but not defined herein shall have the meaning ascribed to such terms in the Agreement.

 

Notwithstanding Sections 2.5 (a) and 8.2 of the Agreement, the Purchaser hereby waives its right to (i) require the resignation of Mr. Moti Rosenberg as a director of the Company and (ii) designate four (4) members to the Company's Board of Directors (the “Board”), and instead will have the right to designate only two (2) members to the Board. The Purchaser agrees that one member of the Board may be designated by the remaining members of the Board immediately following Closing to fill one of the three vacancies on the Board. 

 

This Waiver shall be governed solely and exclusively by and construed in accordance with the internal laws of the State of California without regard to the conflicts of laws principles thereof. 

 

IN WITNESS WHEREOF, the parties hereto have each executed and delivered this Waiver as of the day and year first above written.

 

 

PHILOU VENTURES, LLC

 

By:/s/ Kristine L. Ault

Name: Kristine L. Ault

Title: Manager
III 

119TH CONGRESS 

1ST SESSION S. RES. 8 

Electing Jackie Barber as Secretatry of the Senate. 

IN THE SENATE OF THE UNITED STATES 

JANUARY 3, 2025 

Mr. THUNE submitted the following resolution; which was considered and 

agreed to 

RESOLUTION 

Electing Jackie Barber as Secretatry of the Senate. 

1 Resolved, That Jackie Barber of South Dakota, be, 

2 and she is hereby, elected Secretary of the Senate, effec3 tive January 3rd, 2025. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS
Exhibit 23.1 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

 

We hereby consent to the incorporation by reference in (i) the Registration statements on Form S-8 (Registration Nos. 333-7070, 333-62708, 333-73878, 333-112670,333-105015 and 333-111448) of GlobalSantaFe Corporation, (ii) the Post Effective Amendment No. 1 on Form S-8 to Registration Statement on Form S-4 (Registration No. 333-70268) of GlobalSantaFe Corporation and (iii) the Registration Statement on FormS-3 (Registration No. 333-108643) of GlobalSantaFe Corporation of our report dated March 2, 2005 relating to the financial statements, management’s assessment of the effectiveness of internal control over financial reporting and theeffectiveness of internal control over financial reporting, which appears in the Company’s Annual Report on Form 10-K. We also consent to the incorporation by reference of our report dated March 2, 2005 relating to the financial statementschedule, which appears in this Form 10-K. 

 

PricewaterhouseCoopers LLP

Houston, Texas 

April 7, 2005
IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF TEXAS

DALLAS DIVISION

JOHN DAVID SHOCKLEY, §

§

Plaintiff, §

§ Civil Action No. 3:06-CV-0223-K

v. §

§

UNIVERSITY OF TEXAS MEDICAL §

BRANCH, et al., §

§

Defendants. § 

ORDER ACCEPTING FINDINGS AND RECOMMENDATION

OF THE UNITED STATES MAGISTRATE JUDGE

After reviewing all relevant matters of record in this case, including the Findings,

Conclusions, and Recommendation of the United States Magistrate Judge and any

objections thereto, in accordance with 28 U.S.C. § 636(b)(1), the undersigned District

Judge is of the opinion that the Findings and Conclusions of the Magistrate Judge are

correct and they are accepted as the Findings and Conclusions of the Court.

It is therefore ORDERED that the Findings, Conclusions, and Recommendation

of the United States Magistrate Judge are accepted. For the reasons stated therein, the

Court GRANTS Defendants UTMB, Bowers, Holbrook, and Judd’s Motion for Summary

Judgment (doc. 75). Because there are no claims remaining against Defendants Bowers,

Holbrook, and Judd, the Court dismisses them from this action. 

SO ORDERED.

Signed: May 15 , 2008.

th

____________________________________

ED KINKEADE

UNITED STATES DISTRICT JUDGE
DON’T GET

a Recognize and Avoid

= a SPOOFED
= Se, CALLS

,.6 (CN
WHAT IS SPOOFING? HOW DOES IT WORK?
Spoofing occurs when Caller ID displays your
someone fakes Caller ID caller’s name and number.
details that appear on your But it can be manipulated to
phone to trick you into make it seem someone else
revealing personal is calling.
information.

THINK YOU ARE BEING SPOOFED?

X. ~ 4 & 4:56PM

Personal . Use |
Information Caution

Incoming call

Never give account 877 555 5555 Be careful if you are
numbers, Social Security Customer Solutions being pressured for
numbers, passwords or SoH On inforration

other personal a immediately.

unexpected callers. (2)

Customer Solutions

Seta

Block unknown Password
If a caller claiming to be and unwanted calls

from a government mail account has a
agency or business seeks rt

Inquiries

Make sure your voice

password so spoofers

personal information, :
cannot access It.

hang up and call the
agency or business to
confirm the request.

How do I report suspected spoofing?

If you receive a call and you suspect caller ID information
has been falsified, or you think the rules for protecting
the privacy of your telephone number have been violated,
you can file a complaint with the FCC.

Federal
C. communications twitter.com/fcc
Commission
www.fcc.gov/spoofing instagram.com/fcc
Case 3:06-cv-00252-B Document 13-4 Filed 06/14/06 Page 1 of 5 PageID 60
 

 Case 3:06-cv-00252-B Document 13-4 Filed 06/14/06 Page 2 of 5 PageID 61
 

 Case 3:06-cv-00252-B Document 13-4 Filed 06/14/06 Page 3 of 5 PageID 62
 

 Case 3:06-cv-00252-B Document 13-4 Filed 06/14/06 Page 4 of 5 PageID 63
 

 Case 3:06-cv-00252-B Document 13-4 Filed 06/14/06 Page 5 of 5 PageID 64
SunLink Health Systems, Inc. Disclosure



 EXHIBIT 10.51 
  
 PARENT DISCLOSURE SCHEDULE 
  
 This Parent Disclosure Schedule has been prepared and delivered in accordance with that certain Agreement and Plan of
Merger, dated as of October 15, 2002 (the “Agreement”), by and among SunLink Health Systems, Inc., an Ohio corporation (“SunLink” or “Parent”), HM Acquisition Corp., a Delaware corporation (“Merger Sub”), on
the one hand, and HealthMont, Inc., a Tennessee corporation (the “Company”), on the other hand. Unless the context otherwise requires, terms that are not defined in this Parent Disclosure Schedule shall have the meanings set forth in the
Agreement. The Parent Disclosure Schedule is qualified in its entirety by reference to specific provisions of the Agreement. 







 Section 1.6(a) 
  
 Consideration for Termination of Director Consulting Agreements 
  
 Parent shall issue an aggregate of 35,000 Parent Shares to the following individuals as
indicated below in connection with the Consulting Termination Agreements: 
  

	 Name

	  	Number of
Parent Shares


	 Kay L. Brown
	  	5,000
	 Gene E. Burleson
	  	5,000
	 E. Thomas Chaney
	  	5,000
	 Jay M. Haft
	  	5,000
	 Joel S. Kanter
	  	5,000
	 Richard E. Ragsdale
	  	5,000
	 Arlen B. Reynolds
	  	5,000
	 	  	

	 	  	35,000

  
  
 Section 1.6(b) 
  
 Consideration for LOC Agreements 
  
 Parent
shall issue an aggregate of 60,000 Parent Shares to the following individuals as indicated below in connection with the LOC Agreements: 
  

	 Name

	  	Number of
Parent Shares


	 Gene E. Burleson
	  	7,273
	 E. Thomas Chaney
	  	14,545
	 Chicago Private Investments
	  	18,182
	 Timothy S. Hill
	  	1,818
	 Richard E. Ragsdale
	  	18,182
	 	  	

	 	  	60,000








 Executed as of this 15th day of October, 2002. 
  
 SUNLINK HEALTH SYSTEMS, INC. 
  
  
 By: Robert M. Thornton, Jr.

  
 Its: President and CEO
Lynn M. SCHREIBER and Christine Schreiber, Appellants, v. ARIUM JENSEN BEACH, LLC, and Carroll Management Group, LLC, Appellees.

No. 4D18-1616

District Court of Appeal of Florida, Fourth District.

[March 28, 2019]

**DECISION WITHOUT PUBLISHED OPINION**

*Affirmed.*
Jack Lloyd SWINEY v. STATE

CR-16-0511

Court of Criminal Appeals of Alabama.

October 6, 2017 Reh. denied October 27, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Norman D. REYNOLDS, Appellant, v. STATE of Florida, Appellee.

No. 1D19-0351

District Court of Appeal of Florida, First District.

March 18, 2019 Rehearing Denied May 15, 2019

Norman D. Reynolds, pro se, Appellant.

Ashley B. Moody, Attorney General, Tallahassee, for Appellee.

Per Curiam.

*447Because the notice of appeal was not timely filed, this case is hereby dismissed for lack of jurisdiction. *See* Fla. R. App. P. 9.110(b) ; *Peltz v. District Court of Appeal, Third Dist.* , 605 So.2d 865, 866 (Fla. 1992).

Wetherell, Osterhaus, and Winokur, JJ., concur.
CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002







In connection with the quarterly report of Alchemy Enterprises, Ltd. (the "Company") on Form 10-QSB for the three months ended September 30, 2005, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Harold Sciotto, acting in the capacity as the Chief Executive Officer and Chief Financial Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.





/s/ Harold Sciotto

Harold Sciotto

Chief Executive Officer



November 8, 2005



/s/ Harold Sciotto

Harold Sciotto

Chief Financial Officer



November 8, 2005
1Darnell is a frequent filer in this Court. In this case, the successive

petition for writ of habeas corpus under 28 U.S.C. § 2254 challenges the March

1989, judgment adjudicating guilt for unlawful possession of a prohibited weapon

on the premises of a school in case number 0333956W before the Criminal District

Court Number 2 of Tarrant County, Texas.

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF TEXAS

FORT WORTH DIVISION

ELIGAH DARNELL,Jr., §

Petitioner, §

 §

VS. § CIVIL ACTION NO.4:05-CV-452-Y

 §

DOUGLAS DRETKE, DIRECTOR, §

T.D.C.J.,Correctional § 

Institutions DIV., §

Respondent. § 

 ORDER ADOPTING MAGISTRATE JUDGE'S FINDINGS AND CONCLUSIONS

In this action brought by petitioner Eligah Darnell Jr. under

28 U.S.C. § 2254, the Court has made an independent review of the

following matters in the above-styled and numbered cause:

1. The pleadings and record;

2. The proposed findings, conclusions, and recommendation of the United States magistrate judge filed on

July 14, 2005; and

3. The Petitioner's written objections to the proposed

findings, conclusions and recommendation of the United

States magistrate judge filed on July 29, 2005.

The Court, after de novo review, concludes that Petitioner’s

objections must be overruled, and that the petition for writ of

habeas corpus should be dismissed for the reasons stated in the

magistrate judge's findings and conclusions.1

 It is therefore ORDERED that the findings, conclusions,

and recommendation of the magistrate judge should be, and are

hereby, ADOPTED.

 

 Case 4:05-cv-00452-Y Document 7 Filed 08/08/05 Page 1 of 2 PageID 67
2

It is further ORDERED that Darnell’s Petition for Writ of

Habeas Corpus be, and is hereby, DISMISSED WITHOUT PREJUDICE to his

right to file a motion in the United States Court of Appeals for

the Fifth Circuit for leave to file a successive petition.

SIGNED August 8, 2005,

 

 Case 4:05-cv-00452-Y Document 7 Filed 08/08/05 Page 2 of 2 PageID 68
NOTICE: NOT FOR OFFICIAL PUBLICATION.

UNDER ARIZONA RULE OF THE SUPREME COURT 111(c), THIS DECISION IS NOT PRECEDENTIAL

AND MAY BE CITED ONLY AS AUTHORIZED BY RULE.

IN THE

ARIZONA COURT OF APPEALS

DIVISION ONE

STATE OF ARIZONA, Respondent,

v.

CLEMENTE ARIAS-LUNA, Petitioner.

No. 1 CA-CR 19-0190 PRPC

Appeal from the Superior Court in Maricopa County

No. CR2014-112498-001

The Honorable Teresa Sanders, Judge

REVIEW GRANTED; RELIEF DENIED

COUNSEL

Clemente Arias-Luna, Florence

Petitioner

Maricopa County Public Defender’s Office, Phoenix

By Amanda M. Parker

Counsel for Respondent

MEMORANDUM DECISION

Presiding Judge Samuel A. Thumma, Judge Jennifer M. Perkins and Judge 

Paul J. McMurdie delivered the decision of the Court.

FILED 12-5-2019
STATE v. ARIAS-LUNA

Decision of the Court

2

PER CURIAM:

¶1 Petitioner name seeks review of the superior court's order 

denying his petition for post-conviction relief, filed pursuant to Arizona 

Rule of Criminal Procedure 32.1. This is petitioner's second petition.

¶2 Absent an abuse of discretion or error of law, this court will 

not disturb a superior court's ruling on a petition for post-conviction relief. 

State v. Gutierrez, 229 Ariz. 573, 577, ¶ 19 (2012). It is petitioner's burden to 

show that the superior court abused its discretion by denying the petition 

for post-conviction relief. See State v. Poblete, 227 Ariz. 537, 538, ¶ 1 (App. 

2011) (petitioner has burden of establishing abuse of discretion on review).

¶3 We have reviewed the record in this matter, the superior 

court's order denying the petition for post-conviction relief, and the petition 

for review. Petitioner has not established an abuse of discretion.

¶4 For the foregoing reasons, we grant review but deny relief.
<PAGE>


Exhibit 10.13
                   AGREEMENT FOR JOINT CLINICAL INVESTIGATIONS

Both sides note that the first treatment of autoimmune diseases by removal of
interferons (cytokines) was proposed in 1974 by Professor S.V. Skurkovich
(Nature, 1974;247:551-2). He also proposed to remove TNF-(alpha) in various
autoimmune conditions, including AIDS (J IFN & Cytokine Res 1989;9:S2 and other
publications and patents). The use of anticytokines in autoimmune conditions has
received wide experimental and clinical confirmation in various laboratories of
the world. As is known, organ transplant rejection is also connected with
autoimmune mechanisms. In joint investigations positive results were obtained
with the use of antibodies to interferon-(gamma) in corneal transplants
(Treatment of corneal transplant rejection in humans with
anti-interferon-(gamma) antibodies,. Am J Opthalmol 2002;133:829-30).

Based on this, the State Institute of Transplantation and Artificial Organs of
the Ministry of Health of the Russian Federation ("Institute" herein) in the
person of the Academician Russian Medical and Professor Valery Ivanovich
Shumakov and Advanced Biotherapy, Inc. (ABI- USA) in the person of Professor
S.V. Skurkovich, vice-president of ABI, agree to conduct joint clinical
investigations on the reduction or prevention of organ transplant rejection by
anticytokine therapy. In our joint investigation mainly anti-interferon-(gamma)
antibodies will be used after transplantation of the heart, lung, liver, or
pancreatic beta-islet cells.

Treatment of other conditions besides transplantation is possible.
ABI will supply the Institute with antibodies to interferon g and antibodies to
TNIF-(alpha) and laboratory reagents (immunological) monitoring in accordance
with a protocol for anticyotkine therapy.


[                                   REDACTED                                 ]

Publications of the results of the clinical trials will be done jointly. ABI has
the right to use the results of the trials as it wishes. The first publications
of the treatment of each condition will be in English and the first author will
be a representation of ABI. Later, if any Russian language reports are
published, the first authors will be members of the Institute.

If the Institute wishes to send a representative to a conference outside of
Russia to present the results of the clinical testing, ABI will pay expenses
(registration, travel and hotel) for one attendee per conference.

This agreement is made and signed in English and Russian languages and has the
same validity.


/s/Simon Skurkovich                /s/Valery Ivanovich Shumakov
-------------------------          ------------------------------------------
on behalf of                       on behalf of
Advanced Biotherapy, Inc.          the State Institute of Transplantation and
                                   Artificial Organs of the Ministry of Health
                                   of the Russian Federation

<PAGE>
Exhibit
14.1





CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM





We
consent to the incorporation by reference in Registration Statements Numbers:
333-137691 and 333-104778,  on Form F-3 and in Registration Statement
Number: 333-108304 on Form F-4 of our reports dated March 24, 2009, relating to
(1) the 2008 financial statements and the retrospective adjustments to the 2007
and 2006 financial statements of ABN AMRO Holding N.V., The Netherlands and
subsidiaries, which report expresses an unqualified opinion, and (2) the
effectiveness of ABN AMRO Holding N.V.’s internal control over financial
reporting as at 31 December 2008, appearing in this Annual Report on Form 20-F
of ABN AMRO Holding N.V. for the year ended 31 December 2008.











Amsterdam,
The Netherlands


March 27,
2009




/s/
Deloitte Accountants B.V.
Austin Sean HADLEY v. STATE

CR-16-0736

Court of Criminal Appeals of Alabama.

October 6, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF TEXAS

DALLAS DIVISION

REX ALAN WALKER )

)

V. ) 3-05-CV-1955-N

)

JO ANNE B. BARNHART, )

Commissioner of Social Security )

ORDER ACCEPTING FINDINGS, CONCLUSIONS AND RECOMMENDATION

OF THE UNITED STATES MAGISTRATE JUDGE

United States Magistrate Judge William F. Sanderson, Jr., made findings, conclusions

and a recommendation in this case. No objections were filed. The District Court reviewed the

proposed findings, conclusions and recommendation for plain error. Finding none, the Court

accepts the Findings, Conclusions and Recommendation of the United States Magistrate Judge.

SIGNED December 15, 2006.

 

DAVID C. GODBEY

UNITED STATES DISTRICT JUDGE

 

 Case 3:05-cv-01955-N Document 20 Filed 12/15/06 Page 1 of 1 PageID 145
Case 2:05-cv-00143-J Document 8 Filed 07/13/05 Page 1 of 2 PageID 54
 

 Case 2:05-cv-00143-J Document 8 Filed 07/13/05 Page 2 of 2 PageID 55
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Veterans Affairs

          - [OMB Control No. 2900-0016]

# AGENCY:

Veterans Benefits Administration, Department of Veterans Affairs.

# ACTION:

Notice; withdrawal.

# SUMMARY:

                        On Tuesday, January 7, 2025 the Veterans Benefits Administration (VBA), published a notice in the                         **Federal Register**                         announcing an opportunity for public comment on the proposed collection Claim for Disability Insurance Benefits, Government Life Insurance, VA Form 29-357. This notice was published in error; therefore, this document corrects that error by withdrawing this FR notice.                    

# DATES:

As of January 7, 2025, the FR notice published at 90 FR 1222 on Tuesday, January 7, 2025, is withdrawn.

# FOR FURTHER INFORMATION CONTACT:

                        Maribel Aponte, 202-461-8900,                         *vacopaperworkreduact@va.gov.*

# SUPPLEMENTARY INFORMATION:

FR Doc. 2025-00015, published on January 7, 2025 (90 FR 1222), is withdrawn by this notice.

By direction of the Secretary.

Maribel Aponte,

VA PRA Clearance Officer, Office of Enterprise and Integration/Data Governance Analytics, Department of Veterans Affairs.

[FR Doc. 2025-00580 Filed 1-13-25; 8:45 am]

BILLING CODE 8320-01-P
II 

117TH CONGRESS 

1ST SESSION S. 854 

To designate methamphetamine as an emerging threat, and for other 

purposes. 

IN THE SENATE OF THE UNITED STATES 

MARCH 18, 2021 

Mrs. FEINSTEIN (for herself and Mr. GRASSLEY) introduced the following bill; 

which was read twice and referred to the Committee on the Judiciary 

A BILL 

To designate methamphetamine as an emerging threat, and 

for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Methamphetamine Re5 sponse Act of 2021’’. 

6 SEC. 2. DECLARATION OF EMERGING THREAT. 

7 (a) IN GENERAL.—Congress declares methamphet8 amine an emerging drug threat, as defined in section 702 

9 of the Office of National Drug Control Policy ReauthorVerDate Sep 11 2014 23:33 Apr 03, 2021 Jkt 019200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\S854.IS S854

pbinns on DSKJLVW7X2PROD with BILLS
2 

•S 854 IS

1 ization Act of 1998 (21 U.S.C. 1701), in the United 

2 States. 

3 (b) REQUIRED EMERGING THREAT RESPONSE

4 PLAN.—Not later than 90 days after the date of enact5 ment of this Act, the Director of the Office of National 

6 Drug Control Policy shall establish and implement an 

7 Emerging Threat Response Plan that is specific to meth8 amphetamine in accordance with section 709(d) of the Of9 fice of National Drug Control Policy Reauthorization Act 

10 of 1998 (21 U.S.C. 1708(d)). 

Æ 


pbinns on DSKJLVW7X2PROD with BILLS
# United States Court of Appeals **For the Eighth Circuit**

___________________________ No. 14-3174

___________________________ Richard Bower lllllllllllllllllllll Plaintiff - Appellant v. United States of America lllllllllllllllllllll Defendant - Appellee

____________ Appeal from United States District Court for the Eastern District of Arkansas - Little Rock

____________ Submitted: January 7, 2015 Filed: January 8, 2015 [Unpublished]

____________ Before GRUENDER, BENTON, and KELLY, Circuit Judges.

____________ PER CURIAM. Arkansas prisoner Richard Bower appeals the district court’s 1 dismissal of his pleading seeking to vacate two prior federa l convictions. Because he sought to vacate 1 The Honorable Susan Webber Wright, United States District Judge for the Eastern District of Arkansas.convictions for which he is no longer servi ng the sentences, we conclude his pleading was a petition for a writ of error coram nobis. See Kandiel v United States , 964 F.2d 794, 796 (8th Cir. 1992) (per curiam) (motion seeking to vacate conviction where sentence was already expired shoul d be treated as coram nobis petition). Because Bower must seek such relief in the district courts where he was sentenced on the convictions he seeks to vacat e, dismissal was appropriate. See Mustain v. Pearson , 592 F.2d 1018, 1021 (8th Cir. 1979) (per curiam) (petition for writ of error coram nobis may be filed only in cour t where alleged errors occurred). Accordingly we affirm.

______________________________

-2-